Sanara MedTech Inc. 8-K

What Happened

• On January 23, 2026, Sanara MedTech Inc. announced preliminary financial results for the fourth quarter and full year 2025 via a press release. The company furnished that press release as Exhibit 99.1 to its Current Report on Form 8‑K (Item 2.02). The Form 8‑K notes the furnished information is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference in other filings except as expressly stated.

Key Details

• Filing date: January 23, 2026 (Form 8‑K reporting the press release).
• Subject: Preliminary fourth‑quarter 2025 and full‑year 2025 financial results (earnings/revenue/quarterly results reported in the press release).
• Exhibit: Press release furnished as Exhibit 99.1 to the 8‑K.
• Legal note: Information furnished, not filed under the Exchange Act (limits Section 18 liabilities and incorporation by reference).

Why It Matters

• Preliminary quarterly and full‑year results give investors an early view of Sanara MedTech’s recent earnings and revenue trends ahead of any formal filings or audited statements.
• Because the Form 8‑K furnishes (but does not “file”) the press release, investors should read Exhibit 99.1 and company communications for the specific numbers and context, and watch for subsequent filings (e.g., 10‑K, earnings release) that may provide audited or finalized figures.